This is the biggest trigger behind the surge in Indian Pharma stocks on Friday

Brokerage firm Macquarie is of the view that incremental projects, resulting from the US Biosecure Act, are expected to contribute to revenue and earnings only after a lag that will last between 12 months to 24 months.

Leave a Reply

Your email address will not be published. Required fields are marked *